Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2007 (2007), Article ID 45327, 4 pages
http://dx.doi.org/10.1155/2007/45327
Clinical Study

Serum Interleukin-6 in Patients with Burning Mouth Syndrome and Relationship with Depression and Perceived Pain

1Department of Oral Medicine, West China College of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China
2Department of Oral Medicine, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, Guangdong 510055, China

Received 19 January 2007; Accepted 26 February 2007

Copyright © 2007 Qianming Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Scala, L. Checchi, M. Montevecchi, I. Marini, and M. A. Giamberardino, “Update on burning mouth syndrome: overview and patient management,” Critical Reviews in Oral Biology and Medicine, vol. 14, no. 4, pp. 275–291, 2003.
  2. G. Lauria, A. Majorana, and M. Borgna et al., “Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome,” Pain, vol. 115, no. 3, pp. 332–337, 2005. View at Publisher · View at Google Scholar · View at PubMed
  3. P. Svensson, P. Bjerring, L. Arendt-Nielsen, and S. Kaaber, “Sensory and pain thresholds to orofacial argon laser stimulation in patients with chronic burning mouth syndrome,” Clinical Journal of Pain, vol. 9, no. 3, pp. 207–215, 1993.
  4. S. Gao, Y. Wang, and Z. Wang, “Assessment of trigeminal somatosensory evoked potentials in burning mouth syndrome,” The Chinese Journal of Dental Research, vol. 3, no. 1, pp. 40–46, 2000.
  5. S. M. Heckmann, J. G. Heckmann, and M. J. HiIz et al., “Oral mucosal blood flow in patients with burning mouth syndrome,” Pain, vol. 90, no. 3, pp. 281–286, 2001. View at Publisher · View at Google Scholar
  6. N. J. Rothwell and S. J. Hopkins, “Cytokines and the nervous system II: actions and mechanisms of action,” Trends in Neurosciences, vol. 18, no. 3, pp. 130–136, 1995. View at Publisher · View at Google Scholar
  7. H. Hirota, H. Kiyama, T. Kishimoto, and T. Taga, “Accelerrated nerve regenegration in mice by upregulated expression of interleukin(IL) 6 and IL-6 receptor after trauma,” Journal of Experimental Medicine, vol. 183, pp. 2627–2634, 1996. View at Publisher · View at Google Scholar
  8. J. L. Arruda, R. W. Colburn, A. J. Rickman, M. D. Rutkowski, and J. A. DeLeo, “Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: potential role of IL-6 in neuropathic pain,” Molecular Brain Research, vol. 62, no. 2, pp. 228–235, 1998. View at Publisher · View at Google Scholar
  9. Z. Cao, Y. Gao, and J. B. Bryson et al., “The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth,” Journal of Neuroscience, vol. 26, no. 20, pp. 5565–5573, 2006. View at Publisher · View at Google Scholar · View at PubMed
  10. V. V. Boras, V. Brailo, J. Lukač, D. Kordić, and Z. Blažić-Potočki, “Salivary interleukin-6 and tumor necrosis factor-α in patients with burning mouth syndrome,” Oral Diseases, vol. 12, no. 3, pp. 353–355, 2006. View at Publisher · View at Google Scholar · View at PubMed
  11. D. Simčić, S. Pezelj-Ribarić, R. Gržić, J. Horvat, G. Brumini, and M. Muhvić-Urek, “Detection of salivary interleukin 2 and interleukin 6 in patients with burning mouth syndrome,” Mediators of Inflammation, vol. 2006, Article ID 54632, 4 pages, 2006. View at Publisher · View at Google Scholar · View at PubMed
  12. M. Hamilton, “Development of a psychiatric rating scale for primary depression,” The British Journal of Social and Clinical Psychology, vol. 6, no. 4, pp. 278–296, 1967.
  13. M. Maes, I. Libbrecht, and F. Van Hunsel et al., “The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines,” Psychoneuroendocrinology, vol. 24, no. 4, pp. 371–383, 1999. View at Publisher · View at Google Scholar
  14. P.-J. Lamey, R. Freeman, S.-A. Eddie, C. Pankhurst, and T. Rees, “Vulnerability and presenting symptoms in burning mouth syndrome,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 99, no. 1, pp. 48–54, 2005. View at Publisher · View at Google Scholar · View at PubMed
  15. J. Zhong, I. D. Dietzel, P. Wahle, M. Kopf, and R. Heumann, “Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice,” Journal of Neuroscience, vol. 19, no. 11, pp. 4305–4313, 1999.
  16. A. Geiss, E. Varadi, K. Steinbach, H. W. Bauer, and F. Anton, “Psychoneuroimmunological correlates of persisting sciatic pain in patients who underwent discectomy,” Neuroscience Letters, vol. 237, no. 2-3, pp. 65–68, 1997. View at Publisher · View at Google Scholar
  17. T. Kossmann, V. Hans, H.-G. Imhof, O. Trentz, and M. C. Morganti-Kossmann, “Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes,” Brain Research, vol. 713, no. 1-2, pp. 143–152, 1996. View at Publisher · View at Google Scholar
  18. T. Wyss-Coray and L. Mucke, “Inflammation in neurodegenerative disease—a double-edged sword,” Neuron, vol. 35, no. 3, pp. 419–432, 2002. View at Publisher · View at Google Scholar
  19. E. Andriambeloson, C. Baillet, P.-A. Vitte, G. Garotta, M. Dreano, and N. Callizot, “Interleukin-6 attenuates the development of experimental diabetes-related neuropathy,” Neuropathology, vol. 26, no. 1, pp. 32–42, 2006. View at Publisher · View at Google Scholar
  20. X.-J. Xu, J.-X. Hao, S. Andell-Jonsson, V. Poli, T. Bartfai, and Z. Wiesenfeld-Hallin, “Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section,” Cytokine, vol. 9, no. 12, pp. 1028–1033, 1997. View at Publisher · View at Google Scholar · View at PubMed